Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals
Xeptiva Therapeutics has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Xeptiva Therapeutics's investors include Fen Ventures, Zentynel Frontier Investments, iThink VC, Sergio Fogel, NDLATAM.
Xeptiva Therapeutics is headquartered in Montevideo, Uruguay.
Xeptiva is a biotechnology company developing therapies for the treatment of chronic inflammation in companion animals
Xeptiva Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xeptiva Therapeutics — Funding & Investors." VCBacked, September 23, 2024, https://www.vcbacked.co/company/xeptiva-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Xeptiva Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xeptiva-therapeutics
{{cite web |title=Xeptiva Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xeptiva-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated